NICM
GMED icon

Neo Ivy Capital Management’s Globus Medical GMED Stock Holding History

Neo Ivy Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,206
Closed -$1.74M – 412
2026
Q1 		$1.74M Buy
+20,206
New +$1.81M 0.46% 86
2025
Q4 		– Sell
-10,252
Closed -$587K – 421
2025
Q3 		$587K Buy
10,252
+4,937
+93% +$284K 0.14% 221
2025
Q2 		$314K Sell
5,315
-845
-14% -$54.6K 0.1% 246
2025
Q1 		$451K Buy
+6,160
New +$509K 0.14% 201
2022
Q3 		– Sell
-2,161
Closed -$121K – 445
2022
Q2 		$121K Buy
+2,161
New +$142K 0.32% 105
2021
Q4 		– Sell
-2,960
Closed -$141K – 505
2021
Q3 		$141K Buy
+2,960
New +$238K 0.16% 193
2020
Q4 		– Sell
-4,286
Closed -$212K – 481
2020
Q3 		$212K Buy
4,286
+1,326
+45% +$68.4K 0.21% 187
2020
Q2 		$141K Buy
+2,960
New +$143K 0.16% 193

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Neo Ivy Capital Management's GMED Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 20,206 shares — an estimated $1.74M sold.

Neo Ivy Capital Management first reported a position in GMED in Q2 2020 and held it in 8 quarters. The position peaked at $1.74M in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 20,206 Globus Medical shares in Q2 2026, an estimated $1.74M.
  • Neo Ivy Capital Management first reported a position in Globus Medical in Q2 2020 and held it in 8 quarters.
  • Neo Ivy Capital Management's Globus Medical position peaked at $1.74M in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.